封面
市場調查報告書
商品編碼
1198056

氣道正壓通氣市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Positive Airway Pressure Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

所研究的氣道正壓通氣 (PAP) 市場預計在預測期內的複合年增長率約為 4.6%。

COVID-19 大流行使持續氣道正壓通氣成為人們關注的焦點。 由於對氣道正壓通氣 (PAP) 的需求增加,患有睡眠呼吸暫停的患者在 COVID-19 封鎖期間對 PAP 的依從性顯著增加。 發表在 European Respiratory Journal 2020 上的一篇論文發現,在封鎖的第一個月(2020 年 3 月 15 日至 2020 年 4 月 15 日),4.48% 的 PAP 依從性得到確認。

市場增長的主要驅動因素是久坐不動的生活方式、缺乏身體活動以及肥胖人數增加導致的飲食失調,這些已被確定為睡眠障礙的最常見致病因素。全球睡眠流行率綜合症等疾病正在上升。 例如,根據世界衛生組織2021年報告,2020年將有超過20億18歲以上的成年人超重。 其中,超過 6.5 億人肥胖,導致睡眠呼吸暫停增加。

預計在預測期內,全球睡眠呼吸暫停患病率的增加將提振市場。 根據 Adam V. Benjafield 發表在 Lancet Respiratory Medicine 2020 上的論文,全球有 9.36 億 30-69 歲的成年人患有輕度至重度阻塞性睡眠呼吸暫停 (OSA),而 30-69 歲的成年人中估計有 4.25 億患有中度到嚴重的 OSA。 同樣,50-60% 的肥胖人群和代謝綜合徵 (MS) 患者被認為患有 OSA。 因此,預計睡眠呼吸暫停綜合徵患病率上升將推動氣道正壓通氣市場的增長。

此外,在整個預測期內,人們對睡眠呼吸暫停、心血管疾病和高血壓等風險因素的認識不斷提高,預計也將提振 PAP 市場。

氣道正壓市場趨勢

持續氣道正壓裝置有望在氣道正壓市場佔據最大市場份額

CPAP(持續氣道正壓通氣)是一種氣道正壓通氣,它持續向人的上呼吸道施加大於大氣壓的恆定壓力。 持續氣道正壓通氣 (CPAP) 設備佔據了最大的市場份額,因為它們被用作治療各種睡眠障礙的一線 PAP 療法。

根據《柳葉刀呼吸醫學》2020 年發表的論文“是時候喚醒阻塞性睡眠呼吸暫停的巨人了”,僅在英國,每年約有 800 萬 30-69 歲的人患上阻塞性睡眠呼吸暫停綜合徵 (OSA)。)據說受影響。 對 CPAP 機器的巨大需求在多種情況下幫助了許多睡眠呼吸暫停患者,例如通過控制氣壓和在機器內的泵的幫助下打開阻塞的氣道等氣道阻塞,因為它已被證明。

產品發布和批准、合作夥伴關係、協作和併購等許多市場發展將推動氣道正壓通氣市場的發展。 2019 年 3 月,總部位於美國的醫療器械公司瑞思邁宣布將收購 HB Healthcare (HBH),收購金額不詳。 通過這筆交易,ResMed 將在 HB Healthcare 和值得信賴的分銷商合作夥伴網絡的支持下,接觸到韓國人民,幫助韓國數百萬患有睡眠呼吸暫停、慢性阻塞性肺病和其他呼吸系統疾病的人。希望提供 CPAP和人們的呼吸護理。

患者更喜歡 CPAP 機器,因為它具有多種好處,例如增加能量水平、改善情緒、提高精神警覺性和改善睡眠質量,從而導致這些系統的採用率增加並刺激市場增長。是嗎?

北美主導市場,預計在預測期內也會如此

在整個預測期內,預計北美將主導全球 PAP 市場。 這種主導地位是由於美國糖尿病、高血壓、肥胖、阻塞性睡眠呼吸暫停 (OSA) 和呼吸困難等肺部疾病患病率上升等因素導致對 PAP 設備的需求量增加。 例如,2020 年美國國家醫學研究所發布的一份報告估計,美國 OSA 的患病率男性高達 14%,女性高達 5%。 西班牙裔、黑人和亞裔人口比例較高,推動了預測期內的市場增長。

根據疾病控制和預防中心的行為風險因素監測系統 (BFRSS) 2019,美國成人肥胖率為 42.4%。 這是全國平均水平首次超過40%。 肥胖症的增加正在推動對睡眠呼吸暫停的需求,推動氣道正壓通氣市場。

隨著可支配收入的增加、人口老齡化、空氣污染的迅速增加以及該地區的技術進步,負擔能力的提高也是預測期內全球市場收入中突出的因素。這有助於增加市場分享。

氣道正壓通氣市場競爭分析

持續氣道正壓通氣市場競爭適中,由幾家大型企業組成。 從市場收入的角度來看,目前主導市場的一些知名企業正在積極收購,而其他企業則推出新產品。 例如,2019 年 3 月,瑞思邁收購了 HB Healthcare (HBH),以加強其在韓國 CPAP 和呼吸護理市場的領先地位,提供睡眠呼吸暫停、慢性阻塞性肺疾病 (COPD) 和其他呼吸系統疾病。 目前主導市場的公司包括 Koninklijke Philips NV、ResMed Inc.、Smiths Group PLC、3B Medical Inc. 和 Apex Medical Corp。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 由於人口老齡化和可支配收入增加,全球醫療保健支出增加
    • 全球睡眠障礙患病率上升
    • 技術進步
  • 市場製約因素
    • 在患有大皰性肺病和嚴重流鼻血等疾病的患者中使用這些設備的相關並發症
    • 氣道正壓通氣設備成本高
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分(基於價值的市場規模:百萬美元)

  • 按產品分類
    • CPAP(持續氣道正壓通氣)設備
    • 自動氣道正壓通氣 (APAP) 裝置
    • 雙層氣道正壓 (BiPAP) 裝置
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Koninklijke Philips NV
    • Apex Medical Corp.
    • Compumedics Limited
    • 3B Medical Inc.
    • Medical Depot Inc.
    • ResMed Inc.
    • Smiths Group PLC
    • Fisher & Paykel Healthcare Limited
    • Lowenstein Medical UK Ltd
    • Vyaire Medical Inc.
    • Drive DeVilbiss Healthcare LLC
    • Rotech Healthcare Inc.

第7章 市場機會今後動向

簡介目錄
Product Code: 68172

The positive airway pressure (PAP) market studied was anticipated to witness a CAGR of nearly 4.6% during the forecast period.

The COVID-19 pandemic turned the spotlight on continuous positive airway pressure. Since sleep apnea patients have an increasing demand for positive airway pressure (PAP), adherence to PAP significantly increased during the COVID-19 lockdown. According to the article published in the European Respiratory Journal 2020, a 4.48% increase in PAP adherence was observed during the first month of lockdown (15 March 2020 to 15 April 2020) compared to the same time in 2019.

The major factors attributing to the growth of the market are a rise in the global prevalence of sleep disorders such as sleep apnea due to the rise in the sedentary lifestyle, physical inactivity, and poor dietary habits resulting in increased obesity population, which was identified as the most common causative factor of sleep disorders. For instance, according to the World Health Organization report 2021, in 2020, more than 2 billion adults, 18 years and older, were overweight. Of these, over 650 million were obese, leading to a rise in sleep apnea.

The increasing global prevalence of sleep apnea is expected to boost the market over the forecast period. According to the article published in Lancet Respiratory Medicine 2020 by Adam V. Benjafield, globally, 936 million adults aged 30-69 had mild to severe obstructive sleep apnoea (OSA), and 425 million adults aged 30-69 had moderate to severe OSA. Similarly, it is believed that 50-60% of the obese population and patients with metabolic syndrome (MS) suffer from OSA. Thus, the growing prevalence of sleep apnea is expected to drive positive airway pressure market growth.

Also, increased awareness of sleep apnea and risk factors such as cardiovascular indications and high blood pressure are expected to fuel the PAP market throughout the forecast period.

Positive Airway Pressure Market Trends

Continuous Positive Airway Pressure Devices Expected to Hold the Largest Market Share in the Positive Airway Pressure Market

Continuous positive airway pressure (CPAP) is a type of positive airway pressure ventilation in which a steady pressure larger than atmospheric pressure is continuously applied to a person's upper respiratory tract. Continuous positive airway pressure (CPAP) devices contribute to the largest share in the market because they are used as a first-line PAP therapy to treat various sleep disorders.

According to the article published in The Lancet Respiratory Medicine 2020, "Time to wake the giant of obstructive sleep apnoea", around 8 million people aged 30-69 years are affected by obstructive sleep apnoea (OSA) in the United Kingdom alone each year. The massive demand for the CPAP devices is due to their proven efficiency in many sleep apnea patients in multiple cases, such as airway blockages, by controlling the air pressure with the help of a pump in the device to open up the blocked airways.

Many developments are taking place, including product launches and approvals, partnerships, collaborations, and mergers and acquisitions that can boost the positive airway pressure market. In March 2019, Resmed, a medical equipment firm based in the United States, announced the acquisition of HB Healthcare (HBH) for an undisclosed sum. With this agreement, Resmed hopes to reach out to Korean people with the support of HB Healthcare and its network of trusted distributor partners to provide CPAP and respiratory care to millions of South Koreans suffering from sleep apnea, COPD, and other respiratory disorders.

The patients' increased preference for CPAP devices due to various advantages such as increased energy levels, improved mood, mental alertness, and quality of sleep increase their demand, contributing to the rise in adoption of these systems and fueling the market growth.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the global PAP market throughout the forecast period. The dominance is due to factors such as the rising prevalence of diabetes, high blood pressure, obesity, obstructive sleep apnea (OSA), and pulmonary disorders, such as dyspnea in the United States, which is to higher demand for the PAP devices. For instance, according to reports published by the National Institute of Medicine in 2020, in the United States, OSA prevalence was estimated to be as high as 14% of men and 5% of women. Hispanic, black, and Asian populations have higher rates, which drives the market growth in the forecast period.

According to the Centers for Disease Control and Prevention's Behavioral Risk Factors Surveillance System (BFRSS) 2019, the adult obesity percentage in the United States was 42.4%. This was the first time the national average surpassed 40%. The growing prevalence of obesity increases the demand for sleep apnea, thereby driving the market for positive airway pressure market.

Also, increased affordability with a rise in disposable income, an aging population, a surge in high levels of air pollution, and technological advancements in the region contribute to its outstanding share in the global market revenue during the forecast period.

Positive Airway Pressure Market Competitor Analysis

The continuous positive airway pressure therapy market is moderately competitive and consists of several major players. In terms of market revenue, a few prominent players currently dominating the market are vigorously making acquisitions while others are launching new products. For example, in March 2019, ResMed consolidated its leading role in Korea's CPAP and respiratory care market by acquiring HB Healthcare (HBH) to help millions of South Koreans living with sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Some companies currently dominating the market include Koninklijke Philips NV, ResMed Inc., Smiths Group PLC, 3B Medical Inc., and Apex Medical Corp.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Defination
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Geriatric Population and Rise in Global Healthcare Expenditure, along with Growth in Disposable Income
    • 4.2.2 Rise in Global Prevalence of Sleep Disorders
    • 4.2.3 Advancement in Technologies
  • 4.3 Market Restraints
    • 4.3.1 Complications Associated with the Use of these Devices in Patients with Diseases, like Bullous Lung Disease and Severe Nosebleeds
    • 4.3.2 High Cost of Positive Airway Pressure Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Continuous Positive Airway Pressure (CPAP) Devices
    • 5.1.2 Automatic Positive Airway Pressure (APAP) Devices
    • 5.1.3 Bilevel Positive Airway Pressure (BiPAP) Devices
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle-East
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle-East
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Koninklijke Philips NV
    • 6.1.2 Apex Medical Corp.
    • 6.1.3 Compumedics Limited
    • 6.1.4 3B Medical Inc.
    • 6.1.5 Medical Depot Inc.
    • 6.1.6 ResMed Inc.
    • 6.1.7 Smiths Group PLC
    • 6.1.8 Fisher & Paykel Healthcare Limited
    • 6.1.9 Lowenstein Medical UK Ltd
    • 6.1.10 Vyaire Medical Inc.
    • 6.1.11 Drive DeVilbiss Healthcare LLC
    • 6.1.12 Rotech Healthcare Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS